Akari Therapeutics PLC
NASDAQ:AKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
US |
|
J
|
Johnson Matthey PLC
XBER:JMT2
|
UK |
|
Sparta AG
F:SPT6
|
DE |
|
K
|
Kikkoman Corp
XMUN:KIK
|
JP |
|
Haverty Furniture Companies Inc
NYSE:HVT
|
US |
|
M
|
Medifast Inc
XBER:MDF
|
US |
|
O
|
Oeneo SA
PAR:SBT
|
FR |
|
Robit Oyj
F:RO3
|
FI |
|
T
|
TimkenSteel Corp
NYSE:MTUS
|
US |
|
Medacta Group SA
F:6MD
|
CH |
Wall St Price Targets
AKTX Price Targets Summary
Akari Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
AKTX is 36.38 USD with a low forecast of 27.27 USD and a high forecast of 42 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKTX's stock price target?
Price Target
36.38
USD
According to Wall Street analysts, the average 1-year price target for
AKTX is 36.38 USD with a low forecast of 27.27 USD and a high forecast of 42 USD.